Matches in SemOpenAlex for { <https://semopenalex.org/work/W56313902> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W56313902 endingPage "1752" @default.
- W56313902 startingPage "1752" @default.
- W56313902 abstract "1752 Objectives To assess safety and efficacy of 177Lu-EDTMP in bone pain palliation in breast and prostate cancer patients with bone metastases. Methods Subjects were treated with 177Lu-EDTMP. Criteria for entry into the trial was a positive 99mTc-MDP bone scan consistent with bony metastase pain.Life expectancy is more than 3mo. Results Eleven patients, 6 prostate and 5 breast cancer, aged 65.5±13.8yr (38-84 yr). Seven and four were received 1295 MBq (35mCi) and 2590MBq(70mCi) respectively. 11 patients mean bone lesion score was 14.18 (6-19). In platelet toxicity, 2(18%) of 11 patients developed grade I, 1(9%) developed grade III, 1(9%) developed grade IV. The mean nadir platelet count was 91,1111/mm3at the 4th wk and began to completely recovery from 6th wk; 1(9%) patient developed grade II leucocyte toxicity.The median nadir leucocyte counts was 4,352/mm3 at 2th wk and began to completely recovery from 6th wk. Two subjects did not provide the hematologic counts from 2th wk. Large dose caused more marrow suppression. Table 1 detailed all 11 patients responding almost at 2th wk by the observed trend of pain score, analgesic frequency, mobility, Kamofsky performance. Six, three and two of 11 patients had a duration of palliation of 3, 2, and 1 mo respectively. Conclusions This primarily trial indicated that 177Lu-EDTMP is an effective treatment for palliation of pain from bony metastases. More cases are now being recruited into this study to further examine the efficacy of 177Lu-EDTMP. Research Support IAEA.CRP.E1.30.33,No.1526" @default.
- W56313902 created "2016-06-24" @default.
- W56313902 creator A5000638746 @default.
- W56313902 creator A5002999496 @default.
- W56313902 creator A5030946510 @default.
- W56313902 creator A5037276921 @default.
- W56313902 creator A5051456425 @default.
- W56313902 creator A5053857348 @default.
- W56313902 creator A5075528052 @default.
- W56313902 date "2011-05-01" @default.
- W56313902 modified "2023-09-26" @default.
- W56313902 title "177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial" @default.
- W56313902 hasPublicationYear "2011" @default.
- W56313902 type Work @default.
- W56313902 sameAs 56313902 @default.
- W56313902 citedByCount "0" @default.
- W56313902 crossrefType "journal-article" @default.
- W56313902 hasAuthorship W56313902A5000638746 @default.
- W56313902 hasAuthorship W56313902A5002999496 @default.
- W56313902 hasAuthorship W56313902A5030946510 @default.
- W56313902 hasAuthorship W56313902A5037276921 @default.
- W56313902 hasAuthorship W56313902A5051456425 @default.
- W56313902 hasAuthorship W56313902A5053857348 @default.
- W56313902 hasAuthorship W56313902A5075528052 @default.
- W56313902 hasConcept C121608353 @default.
- W56313902 hasConcept C126322002 @default.
- W56313902 hasConcept C126894567 @default.
- W56313902 hasConcept C141071460 @default.
- W56313902 hasConcept C159110408 @default.
- W56313902 hasConcept C2776139714 @default.
- W56313902 hasConcept C2776235491 @default.
- W56313902 hasConcept C2777783956 @default.
- W56313902 hasConcept C2780192828 @default.
- W56313902 hasConcept C2781156865 @default.
- W56313902 hasConcept C29730261 @default.
- W56313902 hasConcept C2994186709 @default.
- W56313902 hasConcept C530470458 @default.
- W56313902 hasConcept C71924100 @default.
- W56313902 hasConceptScore W56313902C121608353 @default.
- W56313902 hasConceptScore W56313902C126322002 @default.
- W56313902 hasConceptScore W56313902C126894567 @default.
- W56313902 hasConceptScore W56313902C141071460 @default.
- W56313902 hasConceptScore W56313902C159110408 @default.
- W56313902 hasConceptScore W56313902C2776139714 @default.
- W56313902 hasConceptScore W56313902C2776235491 @default.
- W56313902 hasConceptScore W56313902C2777783956 @default.
- W56313902 hasConceptScore W56313902C2780192828 @default.
- W56313902 hasConceptScore W56313902C2781156865 @default.
- W56313902 hasConceptScore W56313902C29730261 @default.
- W56313902 hasConceptScore W56313902C2994186709 @default.
- W56313902 hasConceptScore W56313902C530470458 @default.
- W56313902 hasConceptScore W56313902C71924100 @default.
- W56313902 hasOpenAccess W56313902 @default.
- W56313902 hasRelatedWork W1935659346 @default.
- W56313902 hasRelatedWork W1991889483 @default.
- W56313902 hasRelatedWork W2023493247 @default.
- W56313902 hasRelatedWork W2041788375 @default.
- W56313902 hasRelatedWork W2086584876 @default.
- W56313902 hasRelatedWork W2136505615 @default.
- W56313902 hasRelatedWork W2171817128 @default.
- W56313902 hasRelatedWork W2301475579 @default.
- W56313902 hasRelatedWork W2350284221 @default.
- W56313902 hasRelatedWork W2353291130 @default.
- W56313902 hasRelatedWork W2354614896 @default.
- W56313902 hasRelatedWork W2365350341 @default.
- W56313902 hasRelatedWork W2377000106 @default.
- W56313902 hasRelatedWork W2395859827 @default.
- W56313902 hasRelatedWork W2405691589 @default.
- W56313902 hasRelatedWork W2516914584 @default.
- W56313902 hasRelatedWork W2611138714 @default.
- W56313902 hasRelatedWork W2955757379 @default.
- W56313902 hasRelatedWork W78868755 @default.
- W56313902 hasRelatedWork W96067564 @default.
- W56313902 hasVolume "52" @default.
- W56313902 isParatext "false" @default.
- W56313902 isRetracted "false" @default.
- W56313902 magId "56313902" @default.
- W56313902 workType "article" @default.